Skip to main content

Girish Srinivasan on Behavidence's Data-Driven Mental Health Monitoring

May 31, 2022 ● By Anna Marie Imbordino
Members of the Behavidence Team sitting on a couch.

Members of the Behavidence Team (l-r) Dr. Girish Srinivasan, Dr. Janine Ellenberger, Holly Patrick and Roy Cohen. Photo courtesy of Behavidence.

Palatine-based Dr. Girish Srinivasan brings more than 20 years of experience in medical technology solutions as co-founder and the chief technology officer of Behavidence, a biotechnology company that created a mental health application that generates a daily mental health score. Srinivasan holds a master’s degree in computer science with a focus on artificial intelligence and a doctoral degree in biomedical engineering with a focus on medical imaging and data analytics. His dynamic career path includes leadership roles in research and development, product strategy, clinical research and marketing at Toshiba Medical, GE Healthcare and Samsung Healthcare.

Dr. Girish Srinivasan, photo courtesy of Behavidence

“My passion is to create medical solutions that are accessible and useful tools for everyday life. This is why I partnered with a neuroscientist, a neuropsychologist and a physician in 2020, and we created Behavidence to address the mental health crisis in our country,” he shares.

Srinivasan explains how his educational background in computer science and the medical fields really set the stage for his career. Navigating through different corporate worlds, developing medical device solutions and understanding clinical applications, Srinivasan became aware that even in the United States there is a lack of access to a lot of these technologies.

Behavidence technology monitors behaviors that may be linked to mental health conditions through passive, digital biomarkers. By offering multiple digital phenotyping models that can predict disorders such as depression, anxiety, ADHD and more, individuals can use Behavidence to monitor stress, predict relapse of conditions and more. Mental health providers can screen and remotely monitor patients for clinical interventions and comorbid conditions without interfacing with the patient.

Srinivasan shares that early detection is vital and can help users adjust their behaviors to prioritize rest or reach out to a medical professional before the condition worsens. The longer a user has the app, the clearer the data becomes, enabling more accurate diagnoses, better treatment plans and less extreme mental health issues. He advises, “What it all boils down to is mental health is important, but we won’t be able to solve the mental health concerns of our communities until we start looking at mental health from a data-driven perspective.”

For more information and to download the app, visit Behavidence.com.

Anna Marie Imbordino is an award-winning publicist, writer and environmentalist based in Chicago and Charleston, SC. Connect on social media by following @teawiththebee.